front cover of Biodiversity and Human Health
Biodiversity and Human Health
Edited by Francesca Grifo and Joshua Rosenthal; Foreword by Thomas E. Lovejoy
Island Press, 1997

The implications of biodiversity loss for the global environment have been widely discussed, but only recently has attention been paid to its direct and serious effects on human health. Biodiversity loss affects the spread of human diseases, causes a loss of medical models, diminishes the supplies of raw materials for drug discovery and biotechnology, and threatens food production and water quality.

Biodiversity and Human Health brings together leading thinkers on the global environment and biomedicine to explore the human health consequences of the loss of biological diversity. Based on a two-day conference sponsored by the National Institutes of Health, the National Science Foundation, and the Smithsonian Institution, the book opens a dialogue among experts from the fields of public health, biology, epidemiology, botany, ecology, demography, and pharmacology on this vital but often neglected concern.

Contributors discuss the uses and significance of biodiversity to the practice of medicine today, and develop strategies for conservation of these critical resources. Topics examined include:

  • the causes and consequences of biodiversity loss
  • emerging infectious diseases and the loss of biodiversity
  • the significance and use of both prescription and herbal biodiversity-derived remedies
  • indigenous and local peoples and their health care systems
  • sustainable use of biodiversity for medicine
  • an agenda for the future
In addition to the editors, contributors include Anthony Artuso, Byron Bailey, Jensa Bell, Bhaswati Bhattacharya, Michael Boyd, Mary S. Campbell, Eric Chivian, Paul Cox, Gordon Cragg, Andrew Dobson, Kate Duffy-Mazan, Robert Engelman, Paul Epstein, Alexandra S. Fairfield, John Grupenhoff, Daniel Janzen, Catherine A. Laughin, Katy Moran, Robert McCaleb, Thomas Mays, David Newman, Charles Peters, Walter Reid, and John Vandermeer.

The book provides a common framework for physicians and biomedical researchers who wish to learn more about environmental concerns, and for members of the environmental community who desire a greater understanding of biomedical issues.

[more]

front cover of Mao's Bestiary
Mao's Bestiary
Medicinal Animals and Modern China
Liz P. Y. Chee
Duke University Press, 2021
Controversy over the medicinal uses of wild animals in China has erupted around the ethics and efficacy of animal-based drugs, the devastating effect of animal farming on wildlife conservation, and the propensity of these practices to foster zoonotic diseases. In Mao's Bestiary, Liz P. Y. Chee traces the history of the use of medicinal animals in modern China. While animal parts and tissue have been used in Chinese medicine for centuries, Chee demonstrates that the early Communist state expanded and systematized their production and use to compensate for drug shortages, generate foreign investment in high-end animal medicines, and facilitate an ideological shift toward legitimating folk medicines. Among other topics, Chee investigates the craze for chicken blood therapy during the Cultural Revolution, the origins of deer antler farming under Mao and bear bile farming under Deng, and the crucial influence of the Soviet Union and North Korea on Chinese zootherapies. In the process, Chee shows Chinese medicine to be a realm of change rather than a timeless tradition, a hopeful conclusion given current efforts to reform its use of animals.
[more]

front cover of Out of Nature
Out of Nature
Why Drugs from Plants Matter to the Future of Humanity
Kara Rogers
University of Arizona Press, 2012

About half of all species under threat of extinction in the world today are plants. The loss of plant biodiversity is disturbing for many reasons, but especially because it is a reflection of the growing disconnect between humans and nature. Plants have been used for millennia in traditional systems of healing and have held a significant place in drug development for Western medicine as well. Despite the recent dominance of synthetic drug production, natural product discovery remains the backbone of drug development. As the diversity of life on Earth is depleted and increasing numbers of species become lost to extinction, we continue to lose opportunities to achieve advances in medicine.

Through stories of drug revelation in nature and forays into botany, human behavior, and conservation, Kara Rogers sheds light on the multiple ways in which humans, medicine, and plants are interconnected. With accessible and engaging writing, she explores the relationships between humans and plants, relating the stories of plant hunters of centuries past and examining the impact of human activities on the environment and the world's biodiversity. Rogers also highlights the role that plant-based products can play in encouraging conservation and protecting the heritage and knowledge of indigenous peoples.

Out of Nature provides a fresh perspective on modern drug innovation and its relationship with nature. The book delves into the complexity of biophilia—the innate human attraction to life in the natural world—and suggests that the reawakening of this drive is fundamental to expanding conservation efforts and improving medicine. Rogers's examination of plants, humans, and drug discovery also conveys a passionate optimism for the future of biodiversity and medicine. Including a collection of hand-drawn maps and plant illustrations created by the author, this well-researched narrative will inspire as well as inform.
 


[more]


Send via email Share on Facebook Share on Twitter